Please login to the form below

Not currently logged in


This page shows the latest Abiomed news and features for those working in and with pharma, biotech and healthcare.

Johnson & Johnson to acquire Abiomed in deal worth $16.6bn

Johnson & Johnson to acquire Abiomed in deal worth $16.6bn

Abiomed shareholders will also be entitled to receive up to $35 per share in cash if certain commercial and clinical milestones are achieved. ... The addition of Abiomed provides a strategic platform to advance breakthrough treatments in cardiovascular

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Collected Group

Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...